✦ LIBER ✦

PSM2 THE COST UTILITY OF VARENICLINE IN SMOKING CESSATION HEALTH PROGRAMMES IN SWEDEN

✍ Scribed by K Bolin; H Gilljam; AC Mörk; B Lindgren

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSM2 COST-UTILITY ANALYSIS FOR SMOKING C

✍ A Igarashi; T Fukuda; A Oshima; M Nakamura; K Tsutani 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PSM1 COST-EFFECTIVENESS ANALYSIS OF CHAM

✍ J F Bobadilla; M Brosa; K Wilson; C Sánchez Maestre 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

PSM4 HEALTH ECONOMIC MODEL OF SMOKING CE

✍ A Rasch; C Lenz; W Greiner 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Varenicline as compared to bupropion in

✍ Kristian Bolin; Ann-Christin Mörk; Stefan Willers; Björn Lindgren 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 252 KB

PRS18 COST-UTILITY ANALYSIS OF VARENICLI

✍ A Igarashi; T Fukuda; K Tsutani 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PRS48 Cost-Utility Analysis of Varenicli

✍ Lutz, M.A.; Lovato, P.; Morales, G.; Cuesta, G. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB